Barinthus Biotherapeutics plc (BRNS) — Financial Flexibility Index
Barinthus Biotherapeutics plc (BRNS) has a Financial Flexibility Index of -0.44x as of September 2025. Free cash flow of $-10.73 Million (operating CF $-10.73 Million minus capex $0.00) represents 0% of total liabilities ($24.64 Million). Also explore Barinthus Biotherapeutics plc (BRNS) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Barinthus Biotherapeutics plc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Barinthus Biotherapeutics plc across 6 annual periods. Check BRNS strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Barinthus Biotherapeutics plc (2019–2024)
Year-by-year free cash flow to debt coverage for Barinthus Biotherapeutics plc. For the full company profile including market capitalisation, see BRNS stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.93x | $-28.05 Million | $-28.94 Million | $30.19 Million | ▲ +43.8% |
| 2023 | -1.65x | $-45.51 Million | $-50.92 Million | $27.51 Million | ▼ -438.7% |
| 2022 | -0.31x | $-8.29 Million | $-14.43 Million | $27.00 Million | ▲ +72.5% |
| 2021 | -1.12x | $-31.44 Million | $-32.58 Million | $28.15 Million | ▼ -459.8% |
| 2020 | -0.20x | $-10.73 Million | $-11.03 Million | $53.81 Million | ▲ +56.0% |
| 2019 | -0.45x | $-18.63 Million | $-18.76 Million | $41.12 Million | — |